Ontop pharmaceuticals hiring B.Pharma / BSc diploma in pharmacy and ITI

Vacancy details:

Post Name: Packing Supervisor/Blister Machine Operator/Production Trainee  

Qualification: B.Pharm / B.Sc / Diploma in Pharmacy/ITI

Experienced: 03 to 5 years

Job Description: Greeting from Ontop Pharmaceuticals !!!

Important Details :

• Location:  Hyderabad.
  
• Post of date:08/08/2022
  
• Selection Process: The selection will be on the basis of Interview.

Packing Supervisor:

Department: Production

Experience: 3 years

Qualification: B.Pharm / B.Sc

Skills: Good knowledge on Primary and Secondary Packing.

2. Blister Machine Operator:

Department: Production

Experience: 3 years

Qualification: ITI

Skills: Hands on experience in Blister Machine operating.

3. Production Trainee:

Qualification: B.Sc / Diploma in Pharmacy

Interested candidates can share cv’s to hrhyd@ontoppharma.com

About Ontop pharmaceuticals:

Believe that quality manufacturing is the result of high intention sincere efforts, skillful execution, intelligent directions. our ultra modern facility at Bangalore is WHO, GMP approved.

There are separate sections and departments for the manufacturing of tablets, capsules, ointments etc.

Manufacturing Plant is based Hyderabad and Bangalore, which is the most nature and friendly places in India.

About Pharma industry in India :

India is the world's largest provider of generic medicines by volume with a 20% share of total global Pharmaceutical exports it is also the largest vaccine supplier in the world by volume accounting for more than 50% of all vaccines manufactured in the world. In 1950s foreign companies held the patent of nearly 99% of all Pharmaceutical products under patents in India. With such an exceptional initiative of Indian government the Indian pharmaceutical industry looks incredible positive for attracting more for investments.

✴️Some of the challenges faced by pharmaceutical industry in India are:

👉Lack of research components and real time good manufacturing practices.

👉Inadequate infrastructure for innovation and clinical trials.

👉Increased competition from other countries and price controls.

👉Dependance on China for Active Pharmaceutical Ingredients or APIs

👉Regulatory complaince and quality standards